Valeant Pharmaceuticals (VRX) PT Lowered to $9 at Mizuho Securities
Tweet Send to a Friend
Mizuho Securities lowered its price target on Valeant Pharmaceuticals (NYSE: VRX) to $9.00 (from $11.00) while maintaining a Underperform rating.Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
